V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220012970 | 220007421 | 1.92 | 101.7 | null | 2017-07-20 | 2017-07-24 | Trial Unspecified | 01 | null | 220028665 | TRIAL |
| 220012971 | 220007422 | 1.69 | 61 | Curative (C) | 2014-10-15 | 2014-11-02 | Trial Unspecified | Y | N | 220028667 | TRIAL |
| 220012972 | 220017682 | null | 90 | Palliative (P) | null | 2013-05-13 | AML 19 TRIAL | Y | null | 220028677 | AML19 TRIAL |
| 220012973 | 220017682 | null | 68.2 | Adjuvant (A) | 2016-04-15 | 2016-04-15 | AML 19 TRIAL | null | null | 220028677 | AML19 TRIAL |
| 220012974 | 220017683 | 1.66 | 52.8 | Curative (C) | 2017-01-06 | 2017-02-06 | AML 19 TRIAL | N | N | 220028683 | AML19 TRIAL |
| 220012975 | 220007424 | 1.68 | null | Curative (C) | null | 2014-01-10 | Trial Unspecified | 01 | N | 220028683 | TRIAL |
| 220012976 | 220007426 | 1.69 | 66.2 | Curative (C) | 2016-08-29 | 2016-09-03 | Trial Unspecified | N | N | 220028687 | TRIAL |
| 220012977 | 220014091 | 1.75 | 100.7 | Curative (C) | null | 2015-08-20 | AML 19 TRIAL | 01 | N | 220028687 | AML19 TRIAL |
| 220012978 | 220007427 | 1.68 | 94.5 | Curative (C) | 2015-05-07 | 2015-08-15 | AML 19 TRIAL | N | N | 220028704 | AML19 TRIAL |
| 220012979 | 220007428 | 1.72 | 85.4 | Curative (C) | 2017-02-15 | 2017-02-15 | AML 19 TRIAL | 01 | N | 220028704 | AML19 TRIAL |
| 220012980 | 220007429 | 1.84 | 84 | Curative (C) | 2014-04-30 | 2014-07-14 | AML 19 TRIAL | Y | N | 220028709 | AML19 TRIAL |
| 220012981 | 220007432 | 1.58 | 121.4 | Curative (C) | 2014-05-08 | 2014-05-08 | Trial Unspecified | 01 | N | 220028709 | TRIAL |
| 220012982 | 220007434 | 1.72 | 76.9 | Curative (C) | 2013-06-22 | 2013-06-24 | Trial Unspecified | Y | N | 220028724 | TRIAL |
| 220012983 | 220007435 | 1.8 | 54 | Curative (C) | null | 2016-09-16 | Trial Unspecified | Y | N | 220028725 | TRIAL |
| 220012987 | 220021515 | 1.63 | 64.4 | Curative (C) | 2014-12-05 | 2015-01-26 | AML 19 TRIAL | N | N | 220028735 | AML19 TRIAL |
| 220012988 | 220021515 | 1.63 | 71 | Curative (C) | 2017-07-18 | 2017-07-19 | AML 19 TRIAL | N | N | 220028735 | AML19 TRIAL |
| 220012989 | 220007438 | 1.78 | 63.8 | Curative (C) | 2014-06-01 | 2014-06-03 | Trial Unspecified | Y | N | 220028743 | TRIAL |
| 220012990 | 220007439 | 1.6 | null | Disease modification (D) | 2018-01-16 | 2018-01-16 | Trial Unspecified | 2 | N | 220028760 | TRIAL |
| 220012991 | 220007440 | 1.85 | 60.8 | Disease modification (D) | 2017-04-05 | 2017-04-05 | AML 19 TRIAL | Y | N | 220028763 | AML19 TRIAL |
| 220012992 | 220007444 | 1.68 | 72.6 | Adjuvant (A) | 2014-12-22 | 2014-12-22 | AML 19 TRIAL | Y | null | 220028768 | AML19 TRIAL |
| 220012993 | 220007444 | 1.5 | 75.2 | Disease modification (D) | 2013-08-18 | 2013-08-22 | Trial Unspecified | 1 | N | 220028768 | TRIAL |
| 220012994 | 220007444 | 1.76 | 77.4 | Curative (C) | 2013-10-17 | 2013-10-23 | AML 19 TRIAL | 01 | null | 220028768 | AML19 TRIAL |
| 220012995 | 220007445 | 1.63 | 68.8 | Curative (C) | 2014-11-28 | 2014-12-02 | Trial Unspecified | Y | N | 220028779 | TRIAL |
| 220012996 | 220007445 | 1.7 | 128.4 | Curative (C) | null | 2017-12-18 | AML 19 TRIAL | N | N | 220028779 | AML19 TRIAL |
| 220012997 | 220007445 | 1.56 | 71.8 | Curative (C) | 2016-02-07 | 2016-02-08 | Trial Unspecified | 01 | N | 220028779 | TRIAL |
| 220012998 | 220007446 | null | 84.8 | Disease modification (D) | 2014-06-12 | 2014-06-20 | AML 19 TRIAL | Y | null | 220028784 | AML19 TRIAL |
| 220013001 | 220007451 | null | 57.2 | null | 2017-02-21 | 2017-02-22 | CYTARABINE | N | N | 220028797 | CYTARABINE |
| 220013002 | 220017692 | 0 | null | Palliative (P) | 2012-12-29 | 2013-01-22 | Hydroxycarbamide | N | N | 220028801 | HYDROXYCARBAMIDE |
| 220013003 | 220007453 | 0 | null | Palliative (P) | 2016-07-11 | 2016-07-12 | Hydroxycarbamide | 2 | N | 220028802 | HYDROXYCARBAMIDE |
| 220013004 | 220007454 | 1.66 | 0 | Palliative (P) | 2013-06-22 | 2013-06-23 | AML Interim Guidelines FLA -Ida | N | N | 220028803 | NOT MATCHED |
| 220013005 | 220007456 | null | 64.9 | Curative (C) | 2017-06-03 | 2017-08-24 | EZ | 2 | N | 220028807 | NOT MATCHED |
| 220013006 | 220007458 | 1.78 | 98 | Curative (C) | null | 2017-08-02 | Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE | N | N | 220028807 | NOT MATCHED |
| 220013007 | 220007460 | 1.85 | 20.2 | Curative (C) | 2016-09-29 | 2016-09-29 | null | N | N | 220028814 | NOT MATCHED |
| 220013008 | 220007461 | 0 | 0 | Palliative (P) | 2015-08-04 | 2015-09-17 | AML MyeChild | N | N | 220028822 | NOT MATCHED |
| 220013009 | 220007461 | 1.6 | 41.8 | Curative (C) | 2014-10-05 | 2014-10-27 | null | null | N | 220028822 | NOT MATCHED |
| 220013010 | 220007463 | 0 | 15.85 | Curative (C) | 2017-04-24 | 2017-04-24 | null | null | N | 220028824 | NOT MATCHED |
| 220013011 | 220014109 | 1.57 | 46.2 | Disease modification (D) | 2015-09-15 | 2015-09-19 | Hydroxycarbamide | 02 | N | 220028829 | HYDROXYCARBAMIDE |
| 220013012 | 220014109 | 1.68 | null | null | 2013-02-03 | 2013-02-03 | Hydroxycarbamide | N | N | 220028829 | HYDROXYCARBAMIDE |
| 220013013 | 220007464 | 1.65 | 63.3 | Disease modification (D) | 2018-01-18 | 2018-02-01 | Hydroxycarbamide | 2 | null | 220028832 | HYDROXYCARBAMIDE |
| 220013014 | 220007464 | 1.62 | 60 | Disease modification (D) | 2016-07-15 | 2016-07-15 | Hydroxycarbamide | 2 | null | 220028832 | HYDROXYCARBAMIDE |
| 220013015 | 220007464 | 1.7 | 89.1 | Curative (C) | 2016-06-20 | 2016-07-02 | Hydroxycarbamide | N | N | 220028832 | HYDROXYCARBAMIDE |
| 220013016 | 220007464 | 1.41 | 72.6 | Curative (C) | 2014-08-12 | 2015-05-18 | FBC Conditionining | N | N | 220028832 | NOT MATCHED |
| 220013017 | 220007464 | 0 | 51.5 | Curative (C) | 2016-09-24 | 2016-10-03 | CYTARABINE | 02 | N | 220028832 | CYTARABINE |
| 220013018 | 220007465 | 0.81 | 65 | Curative (C) | 2014-12-22 | 2014-12-28 | CYTARABINE | N | N | 220028859 | CYTARABINE |
| 220013019 | 220007466 | 1.74 | 54 | Disease modification (D) | 2014-07-17 | 2014-07-17 | Hydroxycarbamide | Y | N | 220028861 | HYDROXYCARBAMIDE |
| 220013020 | 220007468 | null | 25.55 | Curative (C) | 2015-10-26 | 2015-11-11 | AML Interim Guidelines FLA -Ida | N | null | 220028863 | NOT MATCHED |
| 220013021 | 220007470 | 1.8 | 64.7 | Palliative (P) | 2016-12-11 | 2017-02-20 | Hydroxycarbamide | 02 | N | 220028866 | HYDROXYCARBAMIDE |
| 220013022 | 220007470 | 0 | null | Curative (C) | 2014-12-18 | 2014-12-19 | CYTARABINE | 2 | N | 220028866 | CYTARABINE |
| 220013023 | 220007471 | 0 | 84.1 | null | 2015-02-07 | 2015-02-10 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220028868 | CYTARABINE |
| 220013024 | 220007473 | 1.7 | 81.6 | Curative (C) | 2016-10-11 | 2016-11-28 | CYTARABINE | N | N | 220028868 | CYTARABINE |